Arrowpoint Investment Partners Singapore Pte. Ltd. Takes Position in Astera Labs, Inc. $ALAB

Arrowpoint Investment Partners Singapore Pte. Ltd. bought a new stake in Astera Labs, Inc. (NASDAQ:ALAB) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm bought 17,382 shares of the company’s stock, valued at approximately $3,403,000. Astera Labs accounts for about 3.4% of Arrowpoint Investment Partners Singapore Pte. Ltd.’s holdings, making the stock its 6th biggest holding.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Assetmark Inc. boosted its stake in shares of Astera Labs by 374.1% in the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after purchasing an additional 101 shares in the last quarter. Pinpoint Asset Management Singapore Pte. Ltd. acquired a new stake in Astera Labs in the third quarter valued at approximately $47,000. Whittier Trust Co. acquired a new stake in Astera Labs in the third quarter valued at approximately $55,000. Ramirez Asset Management Inc. acquired a new position in shares of Astera Labs during the third quarter worth $59,000. Finally, Atlantic Union Bankshares Corp lifted its stake in shares of Astera Labs by 1,338.1% in the 3rd quarter. Atlantic Union Bankshares Corp now owns 302 shares of the company’s stock valued at $59,000 after acquiring an additional 281 shares during the last quarter. Institutional investors own 60.47% of the company’s stock.

Astera Labs Price Performance

Shares of ALAB stock opened at $120.31 on Friday. Astera Labs, Inc. has a one year low of $47.13 and a one year high of $262.90. The company has a market cap of $20.48 billion, a P/E ratio of 98.61, a P/E/G ratio of 2.36 and a beta of 1.74. The firm has a 50-day moving average of $147.89 and a 200-day moving average of $168.18.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, beating the consensus estimate of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The firm had revenue of $270.58 million during the quarter, compared to analyst estimates of $249.46 million. During the same quarter last year, the business posted $0.37 EPS. The company’s revenue for the quarter was up 91.8% on a year-over-year basis. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, research analysts expect that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Jack R. Lazar sold 7,500 shares of Astera Labs stock in a transaction on Thursday, March 5th. The stock was sold at an average price of $119.80, for a total transaction of $898,500.00. Following the sale, the director directly owned 87,351 shares in the company, valued at $10,464,649.80. The trade was a 7.91% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, COO Sanjay Gajendra sold 94,971 shares of the stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total transaction of $11,758,359.51. Following the transaction, the chief operating officer owned 1,531,301 shares of the company’s stock, valued at approximately $189,590,376.81. The trade was a 5.84% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 224,292 shares of company stock worth $27,676,069. 12.50% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the company. Citigroup lowered their price objective on Astera Labs from $275.00 to $250.00 and set a “buy” rating for the company in a research note on Wednesday, February 11th. Morgan Stanley reaffirmed an “overweight” rating and set a $210.00 price target on shares of Astera Labs in a research note on Wednesday, December 3rd. Northland Securities lifted their price target on shares of Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a report on Tuesday, December 9th. Jefferies Financial Group restated a “buy” rating on shares of Astera Labs in a report on Wednesday, December 3rd. Finally, Loop Capital started coverage on Astera Labs in a report on Thursday, March 5th. They set a “buy” rating and a $250.00 target price on the stock. Fifteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Astera Labs has an average rating of “Moderate Buy” and a consensus price target of $202.22.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.